Hjem › Ikke-muskulinvasiv blærecancer › Alabama
Kliniske studier for Ikke-muskulinvasiv blærecancer i Alabama
7 studier for Ikke-muskulinvasiv blærecancer søker deltakere på steder i Alabama.
Byer i Alabama
Offisiell studietekst (engelsk)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- University of Alabama at Birmingham Cancer Center, Birmingham
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07000084Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Urology Centers of Alabama, Homewood
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT06995677A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- The Kirklin Clinic of UAB Hospital, Birmingham
- UAB Infusion Therapy Extended Care Clinic (ECC), Birmingham
- The University of Alabama at Birmingham Investigation Drug Services Pharmacy, Birmingham
- og 1 flere
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07206225A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- University of Alabama at Birmingham, Birmingham
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07309445Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Urology Centers of Alabama, Homewood
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05951179LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- The University of Alabama at Birmingham Clinical Research Unit (CRU), Birmingham
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT04752722Blue Light Cystoscopy With Cysview® Registry
- The University of Alabama at Birmingham, Birmingham
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 18. des. 2025 · NCT02660645Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.